APA (7th ed.) Citation

Chatzipli, A., Bonnefoi, H., MacGrogan, G., Sentis, J., Cameron, D., Poncet, C., . . . Iggo, R. (2021). Patterns of genomic change in residual disease after neoadjuvant chemotherapy for estrogen receptor-positive and HER2-negative breast cancer. British Journal of Cancer, 125(10), 1356. https://doi.org/10.1038/s41416-021-01526-3

Chicago Style (17th ed.) Citation

Chatzipli, Aikaterini, et al. "Patterns of Genomic Change in Residual Disease After Neoadjuvant Chemotherapy for Estrogen Receptor-positive and HER2-negative Breast Cancer." British Journal of Cancer 125, no. 10 (2021): 1356. https://doi.org/10.1038/s41416-021-01526-3.

MLA (9th ed.) Citation

Chatzipli, Aikaterini, et al. "Patterns of Genomic Change in Residual Disease After Neoadjuvant Chemotherapy for Estrogen Receptor-positive and HER2-negative Breast Cancer." British Journal of Cancer, vol. 125, no. 10, 2021, p. 1356, https://doi.org/10.1038/s41416-021-01526-3.